Related Experiment Video
Updated: Oct 13, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Inhibitors of intracellular chloride regulation induce cisplatin resistance in canine osteosarcoma cells
J W Yarbrough1, J I Merryman, M A Barnhill
1Department of Comparative Medicine, University of Tennessee, Knoxville 37901-1071, USA.
Abstract:
The objective of this study was to examine the role of ion transport mechanisms in clinical anticancer drug resistance. Reduction in intracellular accumulation of cisplatin is believed to be an early change in cisplatin-resistant cells, and may be dependent on the concentration of intracellular chloride (Cl-) ions and intracellular pH. The primary aim of this study was to describe the modifying effects of NHMA (5-N,N hexamethylene; amiloride), a Na+/H+ antiport inhibitor, and/or SITS (4-acetamido-4';isothiocyanostilbene-2,2'-disulfonic acid), a HCO3-/Cl- transport inhibitor, in bicarbonate-containing or bicarbonate-free media on cisplatin (cis-diamminedichloroplatinum(II); CDDP) toxicity between known cisplatin-sensitive (COS31) and cisplatin-resistant (COS31/rCDDP) canine osteosarcoma cells. This study has shown that cell survival can be influenced by the inhibition of the Na(+)-dependent HCO3-/Cl- exchanger using SITS. The addition of SITS increases the intracellular Cl- concentration in canine osteosarcoma cells cultured in a bicarbonate-containing media. In a bicarbonate-free media, the addition of SITS results in a decrease in the cytotoxic action of cisplatin.
Insights
Inhibiting the bicarbonate/chloride exchanger with SITS impacts cisplatin resistance in canine osteosarcoma cells. SITS alters intracellular chloride levels, affecting drug toxicity and cell survival.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Anticancer drug resistance, particularly to cisplatin, is a significant clinical challenge.
- Reduced intracellular cisplatin accumulation is a key factor in cisplatin resistance.
- Ion transport mechanisms, including chloride and pH regulation, are implicated in drug resistance.
Purpose of the Study:
- To investigate the role of ion transport inhibitors in modulating cisplatin (cis-diamminedichloroplatinum(II); CDDP) toxicity.
- To examine the effects of Na+/H+ antiport inhibitor NHMA and HCO3-/Cl- transport inhibitor SITS on cisplatin-resistant and sensitive canine osteosarcoma cells.
- To determine how these inhibitors affect cisplatin efficacy in different media conditions.
Main Methods:
- Utilized cisplatin-sensitive (COS31) and cisplatin-resistant (COS31/rCDDP) canine osteosarcoma cell lines.
- Administered cisplatin (CDDP) in conjunction with ion transport inhibitors NHMA and SITS.
- Cultured cells in both bicarbonate-containing and bicarbonate-free media to assess inhibitor effects.
Main Results:
- Inhibition of the Na(+)-dependent HCO3-/Cl- exchanger using SITS significantly influenced cell survival.
- SITS treatment increased intracellular chloride (Cl-) concentration in cells cultured in bicarbonate-containing media.
- In bicarbonate-free media, SITS reduced the cytotoxic effect of cisplatin.
Conclusions:
- Ion transport mechanisms play a crucial role in clinical anticancer drug resistance.
- Targeting the HCO3-/Cl- exchanger with SITS can modulate cisplatin sensitivity and resistance.
- Modulating intracellular chloride levels via ion transport inhibition offers a potential strategy to overcome cisplatin resistance.
Related Concept Videos
Inhibition of Cdk Activity
Treatment Resistant Cancers
Inhibitors of Bacterial DNA Synthesis

